Trials / Completed
CompletedNCT00866385
AZD8566 Food Effect/Microtracer Study
An Open, Randomised, Phase I, 2-Period Crossover Trial to Investigate the Absolute Bioavailability and the Effect of Food on the Oral Bioavailability of AZD8566 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A study designed to look at how the drug AZD8566 is taken up by the body when given with or without food. In some subjects a comparison will be made with a very small labelled microdose given into a vein.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD8566 | Single 6 mg oral solution dose |
| DRUG | AZD8566 IV carbon labelled | Single 10 mcg intravenous carbon-14 microtracer dose |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-03-01
- Completion
- 2009-04-01
- First posted
- 2009-03-20
- Last updated
- 2009-06-09
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00866385. Inclusion in this directory is not an endorsement.